Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro: Implications for atherosclerotic plaque stability

Journal of Clinical Investigation

Volumn 98, Issue 11, 1996, Pages 2572-2579

  Rajagopalan, Sanjay ^a   Meng, Xiao Ping ^b   Ramasamy, Santhini ^a   Harrison, David G ^a   Galis, Zorina S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JILIN UNIVERSITY   (China)

Author keywords

atheroma; extracellular matrix degradation

Indexed keywords

COLLAGENASE;

ANIMAL CELL; ARTICLE; ATHEROMA; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FOAM CELL; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RABBIT;

EID: 10544246489     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119076     Document Type: Article

References (60)

1. Galis, Z.S., G.K. Sukhova, M.W. Lark, and P. Libby. 1994. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94:2493-2503.
2. Nikkari, S.T., K.D. O'Brien, M. Ferguson, T. Hatsukami, H.G. Welgus, C.E. Alpers, and A.W. Clowes. 1995. Interstitial collagenase (MMP-1) expression in human carotid atherosclerosis. Circulation. 92:1393-1398.
3. Shah, P.K., E. Falk, J.J. Badimon, A. Fernandez-Ortiz, A. Mailhac, G. Villareal-Levy, J.T. Fallon, J. Regnstrom, and V. Fuster 1995. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation. 92:1565-1569.
4. Constantinides. P. 1989. Plaque hemorrhages, their genesis and their role in supra-plaque thrombosis and atherogenesis. In Pathobiology of the Human Atherosclerotic Plaque. S. Glagov, W.P.I. Newman, and S.A. Schaffer. Springer-Verlag, New York. 393-412.
5. Falk, E., P.K. Shah, and V. Fuster. 1995. Coronary plaque disruption. Circulation. 92:657-671.
6. Richardson, P.D., M.J. Davies, and G.V. Bom. 1989. Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques. Lancet. 2:941-944.
7. van der Wal, A.C., A.E. Becker, C.M. van der Loos, and P.K. Das. 1994. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation. 89:36-44.
8. Galis, Z.S., G.K. Sukhova, and P. Libby. 1995. Microscopic localization of active proteases by in situ zymography: detection of matrix metalloproteinase activity in vascular tissue. FASEB (Fed. Am. Soc. Exp. Biol.) J. 9:974-980.
9. Lendon, C.L., M.J. Davies, G.V. Born, and P.D. Richardson. 1991. Atherosclerotic plaque caps are locally weakened when macrophage density is increased. Atherosclerosis. 87:87-90.
10. Moreno, P.R., E. Falk, I.F. Palacios, J.B. Newell, V. Fuster, and J.T. Fallon. 1994. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation. 90:775-778.
11. Matrisian, L.M. 1994. Matrix metalloproteinase gene expression. Ann. NY Acad. Sci. 732:42-50.
12. Murphy, G., F. Willenbrock, T. Crabbe, M. O'Shea, R. Ward, S. Atkinson, J. O'Connell, and A. Docherty. 1994. Regulation of matrix metalloproteinase activity. Ann. NY Acad. Sci. 732:31-41.
13. Okada, Y., T. Morodomi, J.J. Enghild, K. Suzuk , A. Yasui, I. Nakanishi, G. Salvesen, and H. Nagase. 1990. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts. Purification and activation of the precursor and enzymic properties. Eur. J. Biochem. 194:721-730.
14. Nagase, H., J.J. Enghild, K. Suzuki, and G. Salvesen. 1990. Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate. Biochemistry. 29: 5783-5789.
15. Galis, Z.S., R. Kranzhöfer, and P. Libby. 1995. Thrombin promotes activation of matrix metalloproteinase-2 (MMP-2) produced by cultured smooth muscle cells. FASEB (Fed. Am. Soc. Exp. Biol.) J. 9:A413.
16. Van Wart, H.E., and H. Birkedal-Hansen. 1990. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci. USA. 87:5578-5582.
17. Suzuki, K., J.J. Enghild, T. Morodomi, G. Salvesen, and H. Nagase. 1990. Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysm). Biochemistry. 29:10261-10270.
18. Griendling, K., J.D. Ollerenshaw, C.A. Minieri, and R.W. Alexander. 1994. Angiotensin II stimulates NADH and NADPH activity in cultured vascular smooth muscle cells. Circ. Res. 74:1141-1148.
19. Matsubara, T., and M. Ziff. 1986. Superoxide anion release by human endothelial cells: synergism between a phorbol ester and a calcium ionophore. J. Cell. Physiol. 127:207-210.
20. Mohazzab, K.M., P.M. Kaminski, and M.S. Wolin. 1994. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am. J. Physiol. 266:H2568-H2572.
21. Segal, A.W., and A. Abo. 1993. The biochemical basis of the NADPH oxidase of phagocytes. Trends Biochem. Sci. 18:43-47.
22. Ohara, Y., T.E. Peterson, and D.G. Harrison. 1993. Hypercholesterolemia increases endothelial Superoxide anion production. J. Clin. Invest. 91: 2546-2551.
23. Rajagopalan, S., S. Kurz, T. Münzel, M. Tarpey, B. Freeman, K. Griendling, and D. Harrison. 1996. Angiotensin II-mediated hypertension in the rat increases vascular superoxide produclion via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone. J. Clin. Invest. 97:1916-1923.
24. Tesfamariam, B. 1994. Free radicals in diabetic endothelial cell dysfunction. Free Radical Biol. Med. 16:383-391.
25. Giugliano, D., A. Ceriello, and G. Paolisso. 1995. Diabetes mellitus, hypertension, and cardiovascular disease: which role for oxidative stress? Metab. Clin. Exp. 44:363-368.
26. Schwartz, C.J., J.J. Ghidoni, J.L. Kelley, E.A. Sprague, A.J. Valente, and C.A. Suenram. 1985. Evolution of foam cells in subcutaneous rabbit carrageenan granulomas. I. Light-microscopic and ultrastructural study. Am. J. Palhol. 118:134-150.
27. Bell, F.P., and R.G. Schaub. 1989. Comparison of lipid accumulation and metabolism in carrageenan-induced granulomas to aorta and blood monocytes of normal and cholesterol-fed rabbits. Exp. Mol. Pathol. 50:327-336.
28. Galis, Z.S., G.K. Sukhova, R. Kranzhöfer, S. Clark, and P. Libby. 1995. Macrophage foam cells from experimental atheroma constitutively produce matrix-degrading proteinases. Proc. Natl. Acad. Sci. USA. 92:402-406.
29. Rosenfeld, M.E., J.C. Khoo, E. Miller, S. Parthasarathy, W. Palinski, and J.L. Witztum. 1991. Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts. J. Clin. Invest. 87:90-99.
30. Gyllenhammar, H. 1987. Lucigenin chemiluminescence in the assessment of neutrophil superoxide production. J. Immunol. Methods. 97:209-213.
31. Hecker, M., W.C. Sessa, H.J. Harris, E.E. Ånggard, and J.R. Vane. 1990. The metabolism of L-arginine and its significance for the biosynthesis of endothelium-derived relaxing factor: cultured endothelial cells recycle L-citrulline to L-arginine. Proc. Natl. Acad. Sci. USA. 87:8612-8616.
32. 3 in cultured endothelial cells. Arch. Biochem. Biophys. 302:348-355.
33. Huie, R.E., and S. Padmaja. 1993. The reaction of NO with superoxide. Free Radical Res Commun. 18:195-199.
34. Strongin, A.Y., I. Collier, G. Bannikov, B.L. Marmer, G.A. Grant, and G.I. Goldberg. 1995. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J. Biol. Chem. 270:5331-5338.
35. Cao, J., H. Sato, T. Takino, and M. Seiki. 1995. The C-terminal region of membrane typo matrix metalloproteinase is a functional transmembrane domain required for pro-gelatinase A activation. J. Biol. Chem. 270:801-805.
36. Galis, Z.S., M. Muszynski, G.K. Sukhova, E. Simon-Morrissey, E.N. Unemori, M.W. Lark, E. Amento, and P. Libby. 1994. Cytokine-stimulated human vascular smooth muscle cells synthesize a complement of enzymes required for extracellular matrix digestion. Circ. Res. 75:181-189.
37. Hanemaaijer, R., P. Koolwijk, L. le Clercq, W.J. de Vree, and V.W. van Hinsbergh. 1993. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester. Biochem. J. 296:803-809.
38. Southgate, K.M., M. Davies, R.F. Booth, and A.C. Newby. 1992. Involvement of extracellular-matrix-degrading metalloproteinases in rabbit aortic smooth-muscle cell proliferation. Biochem. J. 288:93-99.
39. Pauly, R.R., A. Passaniti, C. Bilato, R. Monticone, L. Cheng, N. Papadopoulos, Y.A. Gluzband, L. Smith, C. Weinstein, E.G. Lakatta, and M.T. Crow. 1994. Migration of cultured vascular smooth muscle cells through a basement membrane barrier requires type IV collagenase activity and is inhibited by cellular differentiation. Circ. Res. 75:41-54.
40. Bendeck, M.P., N. Zempo, A.W. Clowes, R.E. Galardy, and M.A. Reidy. 1994. Smooth muscle cell migration and matrix metalloproteinase expression after arterial injury in the rat. Circ. Res. 75:539-545.
41. Zempo, N., R.D. Kenagy, Y.P.T. Au, M. Bendeck, M.M. Clowes, M.A. Reidy, and A.W. Clowes. 1994. Matrix metalloproteinases of vascular wall cells are increased in balloon-injured rat carotid artery. J. Vasc. Surg. 20:209-217.
42. Welgus, H.G., R.M. Senior, W.C. Parks, A.J. Kahn, T.J. Ley, S.D. Shapiro, and E.J. Campbell. 1992. Neutral proteinase expression by human mononuclear phagocytes: a prominent role of cellular differentiation. Matrix Suppl. 1:363-367.
43. Brown, D.L., M.S. Hibbs, M. Kearney, C. Loushin, and J.M. Isner. 1995. Identification of 92-kD gelatinase in human coronary atherosclerotic lesions. Association of active enzyme synthesis with unstable angina. Circulation. 91: 2125-2131.
44. Fliss, H., and M. Menard. 1992. Oxidant-induced mobilization of zinc from metallothionein. Arch. Biochem. Biophys. 293:195-199.
45. Radi, R., J.S. Beckman, K.M. Bush, and B.A. Freeman. 1991. Peroxynitrite-induced membrane lipid peroxidation: the cytotoxic potential of superoxide and nitric oxide. Arch. Biochem. Biophys. 288:481-487.
46. Radi, R., J.S. Beckman, K.M. Bush, and B.A. Freeman. 1991. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of Superoxide and nitric oxide. J. Biol. Chem. 266:4244-4250.
47. Beckman, J.S., T.W. Beckman, J. Chen, P.A. Marshall, and B.A. Freeman. 1990. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc. Natl. Acad. Sci. USA. 87:1620-1624.
48. Beckman, J.S., Y.Z. Ye. P.G. Anderson, J. Chen, M.A. Accavitti, M.M. Tarpey, and C.R. White. 1994. Extensive nitration of protein tyrosines in human atherosclerosis detected by immunohistochemistry. Biol. Chem. Hoppe Seyler. 375:81-88.
49. Haddad, I.Y., G. Pataki, P. Hu, C. Galliani, J.S. Beckman, and S. Matalon. 1994. Quantitation of nitrotyrosine levels in lung sections of patients and animals with acute lung injury. J. Clin. Invest. 94:2407-2413.
50. Ischiropoulos, H., and A.B. al-Mehdi. 1995. Peroxynitrite-mediated oxidative protein modifications. FEBS Lett. 364:279-282.
51. van der Vliet, A., J.P. Eiserich, C.A. O'Neill, B. Halliwell, and C.E. Cross. 1995. Tyrosine modification by reactive nitrogen species: a closer look. Arch. Biochem. Biophys. 319:341-349.
52. Ischiropoulos, H., L. Zhu, and J.S. Beckman. 1992. Peroxynitrite formation from macrophage-derived nitric oxide. Arch. Biochem. Biophys. 298:446-451.
53. Trachtman, H., S. Futterweit, P. Garg, K. Reddy, and P.C. Singhal. 1996. Nitric oxide stimulates the activity of a 72-kDa neutral matrix metalloproteinase in cultured rat mesangial cells. Biochem. Biophys. Res. Commun. 218:704-708.
54. Henney, A.M., P.R. Wakeley, M.J. Davies, K. Foster, R. Hembry, G. Murphy, and S. Humphries. 1991. Localization of stromelysin gene expression in atherosclerotic plaques by in situ hybridization. Proc. Natl. Acad. Sci. USA. 88:8154-8158.
55. Desrochers, P.E., J.J. Jeffrey, and S.J. Weiss. 1991. Interstitial collagenase (matrix metalloproteinase-1) expresses serpinase activity. J. Clin. Invest. 87:2258-2265.
56. Wallaert, B., C. Aerts, B. Gressier, P. Gosset, and C. Voisin. 1993. Oxidative inactivation of alpha 1-proteinase inhibitor by alveolar epithelial type II cells. J. Appl. Physiol. 75:2376-2382.
57. Weiss, S.J., G. Peppin, X. Ortiz, C. Ragsdale, and S.T. Test. 1985. Oxidative autoactivation of latent collagenase by human neutrophils. Science (Wash. DC). 227:747-749.
58. Daugherty, A., J.L. Dunn, D.L. Rateri, and J.W. Heinecke. 1994. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. J. Clin. Invest. 94:437-444.
59. Gaziano, J.M. 1994. Antioxidant vitamins and coronary artery disease risk. Am. J. Med. 97:18S-21S; Discussion 22S-28S.
60. Tanswell, A.K., and B.A. Freeman. 1995. Antioxidant therapy in critical care medicine. New Horiz. 3:330-341.